Alnylam Pharmaceuticals
ALNY
#535
Rank
โ‚น4.116 T
Marketcap
โ‚น31,162
Share price
0.78%
Change (1 day)
31.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company